Form 4 for ISRG Intuitive Surgical
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-28 · accession 0001035267-24-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-29 | 2024-02-28 | ISRG | MOHR MARSHALL | Executive VP Gbl Business S | S - Sale+OE | $385.08 | -108.8K | 47.9K | -69% | -$41.89M |
| DM | 2024-02-29 | 2024-02-28+ | ISRG | MOHR MARSHALL | Executive VP Gbl Business S | M - OptEx | $138.87 | +133.1K | 50.1K | New | +$18.48M |
| DM | 2024-02-29 | 2024-02-29 | ISRG | MOHR MARSHALL | Executive VP Gbl Business S | F - Tax | $386.59 | -1,651 | 49.5K | -3% | -$638.3K |
| DM | 2024-02-29 | 2024-02-28+ | ISRG | MOHR MARSHALL | Executive VP Gbl Business S | M - OptEx | $0.00 | -133.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | S | D | 10,500 | $385.08 | 47,897 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-02-28 | M | A | 10,500 | $182.83 | 58,397 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-29 | F | D | 1,142 | $386.59 | 49,008 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-29 | M | A | 1,003 | $0.00 | 50,011 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-29 | F | D | 509 | $386.59 | 49,502 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-28 | M | A | 13,530 | $242.34 | 40,407 | D | — | — | |
| 7 | Common | Common Stock | 2024-02-28 | S | D | 13,530 | $385.08 | 26,877 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2024-02-28 | M | A | 13,530 | $177.99 | 40,407 | D | — | — | |
| 9 | Common | Common Stock | 2024-02-28 | S | D | 13,530 | $385.08 | 26,877 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2024-02-28 | M | A | 10,500 | $166.62 | 37,377 | D | — | — | |
| 11 | Common | Common Stock | 2024-02-28 | S | D | 10,500 | $385.08 | 26,877 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 12 | Common | Common Stock | 2024-02-28 | M | A | 12,750 | $174.26 | 39,627 | D | — | — | |
| 13 | Common | Common Stock | 2024-02-28 | S | D | 12,750 | $385.08 | 26,877 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 14 | Common | Common Stock | 2024-02-28 | M | A | 12,750 | $139.52 | 39,627 | D | — | — | |
| 15 | Common | Common Stock | 2024-02-28 | S | D | 12,750 | $385.08 | 26,877 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 16 | Common | Common Stock | 2024-02-28 | M | A | 22,500 | $109.49 | 49,377 | D | — | — | |
| 17 | Common | Common Stock | 2024-02-28 | S | D | 14,620 | $385.09 | 34,757 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,620 shares sold at $383.85 to $384.82; 10,760 shares sold at $384.87 to $385.85; and 240 shares sold at $385.90 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 18 | Common | Common Stock | 2024-02-28 | M | A | 22,500 | $79.64 | 57,257 | D | — | — | |
| 19 | Common | Common Stock | 2024-02-28 | S | D | 13,750 | $385.08 | 43,507 | D | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,390 shares sold at $383.85 to $384.82; 10,116 shares sold at $384.87 to $385.79; and 244 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 20 | Common | Common Stock | 2024-02-28 | M | A | 11,250 | $77.00 | 54,757 | D | — | — | |
| 21 | Common | Common Stock | 2024-02-28 | S | D | 6,860 | $385.08 | 47,897 | D | — | — | (F5) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 1,574 shares sold at $383.85 to $384.73; 5,144 shares sold at $384.87 to $385.79; and 142 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 22 | Common | Common Stock | 2024-02-29 | M | A | 2,253 | $0.00 | 50,150 | D | — | — | |
| 23 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-28 | M | D | 11,250 | $0.00 | 0 | D | $77.00 · — to 2026-08-15 | 11,250 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 24 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-28 | M | D | 10,500 | $0.00 | 0 | D | $182.83 · — to 2029-02-15 | 10,500 Common Stock | (F8) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 25 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-28 | M | D | 13,530 | $0.00 | 0 | D | $242.34 · — to 2030-08-28 | 13,530 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 26 | Derivative | Restricted Stock Units | 2024-02-29 | M | D | 2,253 | $0.00 | 0 | D | $0.00 · — to 2024-02-28 | 2,253 Common Stock | (F9) Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. |
| 27 | Derivative | Restricted Stock Units | 2024-02-29 | M | D | 1,003 | $0.00 | 2,004 | D | $0.00 · — to 2026-02-28 | 1,003 Common Stock | (F9) Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. |
| 28 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-28 | M | D | 12,750 | $0.00 | 0 | D | $174.26 · — to 2028-08-15 | 12,750 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 29 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-28 | M | D | 10,500 | $0.00 | 0 | D | $166.62 · — to 2029-08-15 | 10,500 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 30 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-28 | M | D | 12,750 | $0.00 | 0 | D | $139.52 · — to 2028-02-15 | 12,750 Common Stock | (F8) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 31 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-28 | M | D | 22,500 | $0.00 | 0 | D | $109.49 · — to 2027-08-15 | 22,500 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 32 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-28 | M | D | 22,500 | $0.00 | 0 | D | $79.64 · — to 2027-02-15 | 22,500 Common Stock | (F8) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 33 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-28 | M | D | 13,530 | $0.00 | 0 | D | $177.99 · — to 2030-02-28 | 13,530 Common Stock | (F8) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |